Hoppa till innehållet

OMXSPI+0,50%

S&P 500+0,80%

FTSE 100+0,54%

DAX+0,01%

NIKKEI+1,14%
Redeye: Paxman - Time to take notice

Redeye is impressed by the continued strong growth and result progression that was better than expected. The better-than-expected sales and continued bright outlook confirm our positive stance on the potential for Paxman in the future. With some minor adjustments to our estimates due to the beat of our estimates and a slight decrease in sales for 2024e, we maintain our fair value range and range of SEK 39 to SEK 130 per share and lower our Base case value to SEK 84 (86) per share.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Paxman - Time to take notice

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera